Taken together, these findings suggest that in patients with multiple myeloma, serum levels of CRP increase during disease activity and might be significantly correlated with specific disease characteristics including adverse prognostic features such as osteolyses in long weight bearing bones. The gene discussed is CRP; the disease is plasma cell myeloma.